Author:
Patel Miral M.,Adrada Beatriz E.,Nia Emily S.,Kapoor Megha M.,Khazai Laila,Guirguis Mary S.,Perez Frances,Moseley Tanya W.,Arribas Elsa M.
Funder
National Institutes of Health/National Cancer Institute Cancer Center Support Grant
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. American Cancer Society. Key statistics for breast cancer. https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html#:~:text=At%20this%20time%20there%20are,Survival%20Rates%20for%20Breast%20Cancer. Revised January 12, 2023. Accessed 12 Sept 2023.
2. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24(13):2028–37. https://doi.org/10.1200/JCO.2005.04.3273.
3. Kirova YM, De Rycke Y, Gambotti L, et al. Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer. 2008;98(5):870–4. https://doi.org/10.1038/sj.bjc.6604241.
4. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8(10):855–61.
5. Yi M, Huo L, Koenig KB, et al. Which threshold for ER positivity? a retrospective study based on 9639 patients. Ann Oncol. 2014;25(5):1004–11. https://doi.org/10.1093/annonc/mdu053.